NFKB1 and anaplastic large cell lymphoma: In ALK+ ALCL, the CD30 pathway is blocked by NPM-ALK oncoprotein, but STAT3 activity and resultant NFKB2 expression can still be induced by NPM-ALK, leading to minimal alternative NF-κB activation.